We are excited to announce that Anavrin has commenced a new trial in collaboration with the Università degli Studi di Milano . This trial focuses on calves and aims to confirm the effectiveness of our product for use in young ruminants, specifically measuring its...

The European Union (EU) has officially approved a significant regulatory decision to ban the import of edible animal products derived from animals treated with antimicrobial compounds, including Monensin, for growth promotion after September 2026. This regulatory...

We are thrilled to share that our abstract titled "Evaluating the effects of a methane mitigating additive (Anavrin) on feed intake, milk production, and emissions in Holstein dairy cows," developed at Wageningen University & Research, has been accepted for...

We are thrilled to announce the remarkable outcomes of a one-of-a-kind trial in Europe, conducted over an extensive 210 days (7months) in collaboration with Università degli Studi di Milano. This extensive period allowed us to gain unparalleled insights into measuring...

4,000 pregnant Hereford heifers are successfully fed with Anavrin in the region of Durazno in Uruguay in collaboration with Agrifirmuy This achievement underscores our commitment to advancing agricultural practices while prioritizing sustainability. By utilizing...

We are thrilled to announce that Anavrin has been chosen by AgroServ, part of the 🇪🇺 European Union's initiative, for the AgroServ Project! This recognition enables us to gain access to key EU research services, enhancing our contributions to sustainable agriculture....

We are thrilled to announce the establishment of our new hashtag#subsidiary in Turkey! This strategic move allows us to develop and directly manage the sales of our innovative product, Anavrin within this promising region. Turkey, home to over 52 million of ruminant...